Infinity Pharmaceuticals, Inc. (INFI) Posts Q1 EPS Loss of $0.09, Tops Consensus by 25c, Post Strong FY11 Guidance
Tweet Send to a Friend
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.09), $0.25 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
